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Abstract
The β− based radio-guided surgery overcomes the corresponding γ
technique in case the background from healthy tissues is relevant. It can
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be used only in case a radio-tracer marked with 90Y is available since
the current probe prototype was optimized for the emission spectrum of
this radio-nuclide. Here we study, with a set of laboratory tests and
simulations, the prototype capability in case a different radio-nuclide is
chosen among those used in nuclear medicine.
As a result we estimate the probe efficiency on electrons and photons
as a function of energy and we evaluate the feasibility of a radio-guided
surgery exploiting the selected radio-nuclides. We conclude that requiring
a 0.1 ml residue to be detected within 1 s by administering 3 MBq/Kg of
radio-isotope, the current probe prototype would yield a significant signal
in a vast range of values of SUV and TNR in case 31Si,32P, 97Zr, and
188Re are used. Conversely, a tuning of the detector would be needed to
efficiency use 83Br, 133I, and 153Sm, although they could already be used
in case of high SUV or TNR values. Finally, 18F,67Cu, 131I, and 177Lu
are not useable for radio-guided surgery with the current probe design.
Introduction
Radio-guided surgery (RGS) is a technique that enables the surgeon to evalu-
ate in real time the completeness of the tumor lesion resection. At the same
time RGS allows to minimise the amount of healthy tissue removed. It repre-
sents a significant adjunct to intra-operative detection of millimetre-sized tumor
residues, providing the surgeon with vital and real-time information regarding
the location and the extent of the lesion. It is crucial for those tumors where
surgical resection is the only possible therapy, since it reduces the probability
of tumor recurrence assessing surgical resection margins.
RGS makes use of a radio-labelled tracer and of a probe. The radiophar-
maceutical is administered to the patient before surgery and its uptake has to
be higher in the tumor than in healthy organs, allowing to discriminate among
them.
Traditional RGS makes use of γ emitters as tracer [1, 2, 3]. However, the
use of this technique is strongly limited, and often even prevented, by the back-
ground produced from the uptakes of the healthy tissue. Such a background is
non-negligible because γ radiation can travel through large amounts of tissue.
Moreover, the large mean free path of γ radiation exposes the medical personnel
to radiation risks.
The use of β− radiation to overcome the limitations of traditional RGS
was recently proposed [4, 5]. Indeed, electrons have a very small penetration.
Therefore a β− RGS has a more favourable ratio between the signal coming from
the tumor and the rest of the body. An ex-vivo test has shown the feasibility of
this technique for a meningioma case [6]. Meningioma has been chosen because
it is known to express receptors to DOTATOC [7], a somatostatin analogue that
could be labelled with 90Y, a pure β− emitter with a 2.3 MeV electron energy
endpoint.
Limiting to such radio-tracer, though, would mean restricting this technique
to very few tumors, mainly glioma [8] and neuro-endocrine tumors [9]. To
further broaden the applicability of the technique, the use of different radio-
isotopes, with larger gamma contamination and lower endpoint is under inves-
tigation.
Among the β−-emitting radio-isotopes that have the largest diffusion in nu-
Isotope τ1/2(h) Eγ (keV) Iγ (%) EPβ (keV) Iβ (%)
31Si 2.62 1491 100
32P 343 1710 100
67Cu 62 93 16 377 57
184 48 468 22
561 20
83Br 2.4 935 99
90Y 64 2280 100
97Zr 17 743 93 759 88
(secondary*) 657 86 1277 86
131I 192 365 82 334 7
637 7 606 90
133I 20.8 530 87 1227 83.4
153Sm 46 103 29 635 31
704 49
808 18
177Lu 160 112 6 177 12
208 10 500 79
188Re 17 155 15 1962 25
2118 72
Table 1: Characteristics of the β− radio-isotopes of interest for the proposed
RGS technique: half-life (τ1/2), γ and β
− intensities (Iγ , Iβ), photon lines energy
(Eγ), and β
− end-points (EPβ). Only components with I > 5% are listed.(*)
the second line of 97Zr is due to the subsequent decay, with τ1/2 = 72 min of
the 97Nb produced in the primary decay.
clear therapy [10], we considered those that have an electron energy end-point
of at least 500 keV, dominant γ lines below 300 keV and total γ intensities
below 100%: 32P, 131I, 133I, 153Sm, 177Lu, and 188Re. In addition we considered
isotopes that are chemically in the same family as nuclides already used to mark
tracers since these are the best candidates to give life to a new radio-tracer. We
thus included in our studies 31Si, 67Cu, 83Br, and 97Zr. The characteristics of
the decays of the considered isotopes are detailed in Tab. 1.
Figure 1: The probe prototype and the experimental setup of the measurents
with the sealed point-like sources (left) and scheme of the setup with 18F (right).
Another alternative is to consider 18F, which has τ1/2 = 1.8 h and a β
+ emis-
sion with end-point at 633.5 keV and 97% intensity and is used to radio-label
the fluorodeoxyglucose (FDG). The uptake of the latter is the same as glucose,
which in turn is correlated with tissue metabolism. It is widely used as marker
for the positron emission tomography (PET) and, therefore, if the developed
probe were sensitive to 18F with low background there would be a significant
extension of the applicability of the technique. It is to be noted that in this
case the probe would detect the positrons before they stop or annihilate, while
annihilation photons would represent a background. The possibility to intra-
operatively detect β+ decays has already been explored in the past [11, 12] with
the development of ad-hoc dual detectors for the simultaneous measurement of
positrons and γs. The difficulties in developing and handling the probe has
limited the clinical studies [13].
This paper describes the laboratory tests performed to measure the probe
efficiency to γ and β radiations, studies that are the basis for the extention
of the technique to radio-isotopes other than the baseline 90Y. To investigate
potentialities of radiations significantly different, several sources with different
β spectra and gamma lines were used.
After tuning the simulation on these measurements, the expected signal from
tumor and background assuming to use the different possible radionuclides of
Tab. 1 was estimated. Finally in the comparison among radio-isotopes we also
estimated the expected dose rate delivered to the medical personnel during
surgery. This requirement, in addition to the need to minimize the dose to the
patient, limits the activity that can be administered.
Material and Methods
The Probe Prototype
The probe prototype considered in this paper is visible in Fig. 1. The lower
black part in the picture is a ring of 12 mm external diameter in Acrilonitrile
Butadiene Stirene (ABS) that shields the sensitive element content in it from the
radiation coming from the side. The sensitive part of the probe is a 3 mm height
and 5 mm diameter of mono-crystalline para-terphenyl doped to 0.1% in mass
with diphenylbutadiene. This plastic scintillator was adopted because of its high
light yield (∼3 times larger than typical organic scintillators), non-hygroscopic
property, and low density [14] that minimises the sensitivity to photons. The
light tightness around the scintillator is ensured by a 15µm thick aluminum
sheet. The scintillation light is read out by a SiPM (sensL B-series 10035)
biased with 24.5 V. Its spectral range is 300− 800 nm and the peak wavelength
is 420 nm. An aluminum cylindrical body (diameter 12 mm and length 14 cm)
encapsulates this assembly. A portable electronics based on ArduSiPM, with
ethernet connection to a PC was used for the read out [15].
Experimental Setups
We measured the probe sensitivity to the radiation emitted by several long
life-time radioisotopes with different energies, contained in sealed sources and
in liquid 18F samples. They contain radio-isotopes by definition different from
the ones of interest to RGS, which requires half-lives shorter than few days.
Therefore these measurements can only been used to optimize the parameters
used in the MC simulations (see Sec. ) to describe the probe behavior, in
particular the optical properties of para-terphenyl. The MC is in turn used to
estimate the RGS performances.
This measurement campaign has been performed with two different setups:
the setup used for the sealed laboratory sources and the one made to measure
the probe efficiency to liquid 18F. These two setups will be described separately
in the next subsections.
Isotope A (kBq) τ1/2 (y) Eγ (keV) I (%) EPβ− (keV) I (%) EPβ+ (keV) I (%) e
− (keV) I (%)
60Co 36.7± 1.1 5.3 1173 100 317 100
1332 100
90Sr 3.3± 0.1 28.9 540 100
2280 100
22Na 40.5± 1.2 2.6 511 181 546 90
1274 100
152Eu 41.5± 1.2 13.2 40 58 384 2.4 75 19
45 11 694 14 114 11
122 28 1475 8 120 2.4
244 8
344 27
443 3
779 13
867 4
964 15
1085 12
1112 4
1408 21
Table 2: Characteristics of the sealed sources used in the tests: activity at
the moment of the experiment (A), half-life (τ1/2), intensities (I), photon lines
energy (Eγ), and end-points (EP).
Sealed sources setup
The sealed sources were chosen in order to test the efficiency to photons and
electrons at several energies. Their relevant characteristics are listed in Tab. 2.
The γ sources have also β decays from internal conversion. Since the amount
of electrons exiting the source depends strongly on the its details, we added a
2.8 mm copper shielding.
All the sealed sources were point-like a part the 90Sr one that had a diameter
of 16 mm . The probe was placed vertically on top of each of them, 3.5 mm far
from the sources. A picture of the experimental setup is in the left of Fig. 1.
A bi-dimensional horizontal scan was performed for each measurement in order
to center the probe with respect to the source.
Finally, to study different electron spectra, the measurements with the 90Sr
were repeated also with a plastic shielding made of up to 11 sheets of 2-methyl-
1,3-butadiene, 400 µm thick.
18F setup
To measure the probe efficiency to 18F, 0.48 ml of water with 53 kBq of such
isotope have been placed in a plastic (PVC) vessel, its central water receptacle
was cylindrically shaped, with a diameter of 12.2 mm. To shield from γ radia-
tion, the plastic vessel has been placed in a lead vial, also cylindrically shaped.
The lead vial was much larger than the plastic vessel to reduce the background
due to the annihilation γ’s. In detail: the vial internal radius was 2 cm and the
distance from the bottom 4.4 cm. A scheme of the experimental setup, with the
most relevant sizes of the lead vial shield and the vessel, is shown in Fig. 1 on
the left.
The Probe Simulation and its Optimization
The estimate of the expected performances of the β− probe prototype in case of
use of β+ radio-tracers for intra-operatorial use requires an estimate of the signal
from the tumor and of the background coming from the uptake of radio-tracer
from the rest of the body. These measurements need a simulation properly
reproducing the measurements on the sources.
Furthermore, this study aims to quantify the efficiency on electrons and pho-
tons as a function of their energies and this also requires a detailed simulation.
To this aim, the FLUKA Monte Carlo (MC) code [16] was used for a full
simulation of the probe and of the experimental setups. From the geometry of
the setup and of the probe the program estimates the energy released in the
interaction of the decay products of the radio-nuclides with the detector and
produces 28000 optical photons per MeV of deposited energy [14]. To increase
the simulation precision, the δ rays production threshold and the electron trans-
port threshold have been set to 10 keV in the scintillator and in the material in
contact with it. Moreover, in these materials the electrons step size has been
limited to make them lose no more than 1% of their energy per step. This allows
to accurately reproduce the optical photons generation points and the δ rays
production at the interface with the scintillator. In all the other materials the
transport threshold of all the particles and the δ ray production threshold are
set at 100 keV. The path of the optical photons is traced within the probe and
the number of optical photons reaching the light detector (SiPM) is counted
(Nop). The fraction of the decaying nuclei that release a signal is computed as
the fraction of simulated decays that has Nop greater than a threshold (Nth)
representing the minimum signal detectable by the probe prototype. Such effi-
ciency (MC) depends therefore on this threshold.
The simulation has several parameters which need to be set empirically. The
ones that are most relevant for this analysis are related to the optical properties
of the para-terphenyl, since they determine the conversion between the released
energy and Nop. While the attenuation length has been measured to be ≈2 cm,
the diffusion coefficient (D expressed in cm−1) and the reflectivity (r) of the
aluminum-wrapping were varied to find the configuration that best reproduces
the measurements. Finally also Nth, related to the electronic threshold applied
at readout, is optimized on data.
The optimization of these parameters is based on the measurement of the
maximum observed rates in the scans over Ns − 1 sealed sources described in
Sec. 1 and the 18F setup described in Sec. : Ri, i = 1, ..., NS . Such mea-
surements are divided by the corresponding source activity (Ai), to estimate
the efficiency on data, DTi = Ri/Ai, with an error estimated as the sum in
quadrature of the statistical error on Ri and the uncertainty on Ai (see Tab. 2).
At the same time, for each source the MC estimates the efficiency for each
possible value of the free parameters (
−→
P = {D, r,Nth}): MCi (−→P ). The best
estimates of the parameters are those that minimize
χ2(
−→
P ) =
∑
i
(
MCi (
−→
P )− DTi
σi
)2
. (1)
1of the described setups we used in the minimization only part of the measurements with
90Sr, both to avoid giving too much wight on the electron detection and to have a control
sample (see right of Fig. 3).
Estimate of expected RGS performances
In order to quantify the performances of the probe on different radio-isotopes, a
benchmark surgical configuration was established. We considered that a typical
patient of 70 kg of weight could be administered ≈ 210 MBq, and that a typical
SUV of interest could range between 1 and 8, with a ratio between the uptake
in the tumor and in the nearby healthy tissue (TNR) ranging between 4 and
30, as established in our previous studies on cerebral tumors [8].
Figure 2: Geometry of the simulation used to estimate the far background
To estimate the discrimination power between tumor and healthy tissues, we
performed, for each radio-isotope, two sets of MC simulations: one to evaluate
the signal from a tumor residue and the background due to the radiation emitted
from the nearby healthy tissue; the other one to evaluate the background, mostly
due to γ emission resulting from the uptake in the whole body. The acquired
information was then combined to estimate the minimum time needed to identify
a tumor residue or the minimum specific activity that needs to be administered
to have a timely response from the probe.
Signal From Tumor and Nearby Healthy Tissues
To estimate the signal that we would measure from a small residue embedded
in healthy tissue, we simulated a 6 mm diameter, 7 mm height cylinder with
activity AT = AM ∗SUV (where AM is the mass specific administered activity),
representing the residue, encapsulated in the center of a 2 cm diameter, 1 cm
height cylinder with activity AB = AT /TNR, representing the healthy tissue.
The estimated rate is RTum.
Conversely, to estimate the signal we would have on the nearby healthy
tissue, a 2 cm diameter, 1 cm height cylinder completely active with AB was
simulated. The estimated rate is RNear.
Far Background
The simulation was performed on a sample PET/CT scan provided by the Osirix
web site2 (see Fig. 2). The CT voxels, have been converted from Hounsfield
Units (HU) into density and elemental composition for MC simulation[17]. The
spatial distribution of the isotopes is sampled using the FDG-PET scan of the
same patient, thus assuming for the hypothetical radio-tracer the same uptake
as the FDG.
2 the DICOM file called “MELANIX” on http://www.osirix-viewer.com/datasets/
To increase the simulation efficiency, and to average on different possible
positions of the probe with respect to the patient body, 50 replicas of the probe
were simulated and the average counting rate (RFar), scaled for the total ac-
tivity in the patient, was considered as background rate. The probes were
conservatively placed on the abdomen of the patient.
To avoid double counting the background from nearby healthy tissues, in the
estimate of the far background contributions from decays in a fiducial volume
around the probe were discarded. Eventually, the signal expected when the
probe is in contact with a tumor residue (Sres) or healthy tissue (SHT ) are
estimated as:
SRes = RTum +RFar (2)
SHT = RNear +RFar (3)
Minimum Time Needed and Administered Activity
The benchmark of the feasibility of the use of a given radiation is the activity
that needs to be administered to have a significant signal in a reasonable time.
We consider to be able to efficiently detect residues if the probability of false
negatives FN< 5% and of false positives FP< 1%3. Under these conditions,
as described in Ref. [8] we can calculate tminprobe, the time needed to have such
a response given the administered activity and Amin1s , the mass specific activity
needed to have a reasonable time response of tminprobe = 1 s.
Estimate of Medical Staff Exposure
Another critical information to establish the feasibility of an RGS technique is
the dose received by the medical personnel. Given that a reasonable limit on the
dose received by the medical personnel is 1 mSv/year, the dose rate induced by
the activity administered to the patient defines the maximum number of hours
that the surgical staff can operate adopting the RGS.
Given the limited penetration of the β− radiation we consider that the dom-
inant contribution to the dose to the surgical staff comes photons. Therefore,
we estimate the expected effective dose rate from the specific gamma-ray dose
rate (Γ) calculations in Ref. [18]. In the case of pure β− decays we consider
the effective dose delivered by the Brehmsstrahlung radiation as computed in
Ref. [19]. From the estimated Γ values we extract DRmed, the expected dose
rate on the medical staff in case 3MBq/kg of radio-isotope is administered to a
70 kg patient and the person is on average at a distance of 1 m. The estimated
values are reported in Tab. 3.
Results
Simulation Parameter Optimization
The optimization of the MC parameters, the diffusion coefficient D, the reflec-
tivity (r) and the equivalent threshold in optical photons (Nth), were determined
as described in Sec. .
3FN and FP are computed from SRes and SHT as described in Ref. [8]
Figure 3: Left: χ2 as a function of the diffusion coefficient (D) and the reflectiv-
ity (r) after the optimization of Nth.Right: Comparison between experimental
counts and MC for the optimized values of D and r. The residual discrepancy
(exp/MC) is also shown. Green bins in the bottom panel indicate the sources
included in the χ2 minimization.
The measured χ2 as a function of D and r is shown in Fig. 3 on the left.
There is a clear correlation between the two parameters, a lower reflectivity
being compensated by a lower diffusion parameter. Nonetheless there is a well
defined minimum in r=80% and D=1.2 cm−1 and these are the adopted param-
eters in the remaining of the paper.
Fig. 3 on the right shows the resulting level of agreement of the measured
and estimated rates together with the fractional discrepancy between the two.
Efficiencies
After fixing the MC parameters, the efficiency of the probe on electrons and
photons could be estimated as a function of the energy. The result is reported
in Fig. 4: the efficiency on electrons reaches a plateau of 95%, the flexus of
the distribution being ≈400keV. Similarly, the photon efficiency reaches 1.2%
at ≈ 800 keV and has a less steep raise.
These observations confirm that the probe is optimal for 90Y and that it has
low sensitivity to photons. The performances are also significantly better than
the previous prototype with PMT readout [20].
Figure 4: Probe efficiency as a function of the electron (top) and photon (bot-
tom) energy.
RGS Feasibility
In order to compare the expected performances of the current probe prototype
among radio-isotope, the simulation has been run as described in Sec. , assuming
a 70 kg patient with SUV ranging between 1 and 8 and TNR between 4 and 30.
Tab. 3 reports the relevant information for a particular case, with a reasonable
SUV (4) and TNR (8). As a reference also the results obtained by the same
analysis with the golden radio-isotope, 90Y, are reported.
The extrapolation to other values of SUV and TNR are shown in Fig. 5.
Table 3: Comparison between radio-isotopes: the expected signal on a residue
(Sres) and on healthy tissues (SHT ) and the contribution from the far back-
ground (Rfar); the minimum time required to identify a residue as defined in
the text(tminprobe); the dose rate to the medical personnel(DRmed) if 3 MBq/kg
are administered and the average distance from the patient is 1 m; and the min-
imum mass specific activity (Amin1s ) needed to have t
min
probe = 1 s, These estimates
are obtained assuming SUV=4, TNR=8.
Isotope Sres SHT RFar t
min
probe A
min
1s DRmed
(cps) (cps) (cps) (s) (MBq/kg) (µSv/hr)
18F 38 35 33 >25 >75 38
31Si 38 10 2.3 0.4 1.3 0.027
32P 48 13 2.5 0.4 1.2 0.027
67Cu 1.4 1.3 1.2 >25 >75 4.8
83Br 9.6 1.8 0.3 1.2 3.7 0.29
90Y 71 26 6.1 0.4 1.2 0.027
97Zr 319 143 102 0.1 0.4 6.1
131I 12 10 9.9 >25 >75 16
133I 44 28 23 2.2 6.5 23
153Sm 3.0 0.7 0.3 4.7 14 5.0
177Lu 0.6 0.4 0.3 >25 >75 1.6
188Re 55 18 4.3 0.5 1.4 2.1
Discussion
This study compares the performances of a prototype probe optimized for 90Y
detection on further radio-isotopes of interest. The results obtained are very
important to guide on one side the choice of possible radio-tracers, on the other
side the design of future prototypes.
The results indicate that three classes of radioisotopes can be identified:
• those that can be used with the current prototype alternatively to 90Y:
31Si,32P, 97Zr, and 188Re. Most of these isotopes are even more favor-
able than 90Y since they have an electron energy endpoint low enough
to limit the background from nearby healthy tissues, but high enough for
the probe to be efficient. It is to be noted that lowering the minimum
detectable energy would help anyhow, because it would allow detection
also of partially infiltrated residues that are not completely at contact.
Figure 5: Minimum mass specific activity needed to have a discriminating re-
sponse from the probe in less than 1 s as a function of TNR for SUV=1 (top)
and SUV=4(center) and SUV=8 (bottom). In the left plot all the points corre-
sponding to 133I and 153Sm are above the maximum in the axis.
• those that would profit significantly from a tuning of the detectable energy
threshold: 83Br, 133I, and 153Sm. It is though to be noted that, for SUV≥4
and TNR> 5, 83Br and 133I yield significant signals.
• those that in addition to a reduction in detectable energy threshold would
require also further photon suppression: 18F,67Cu, 131I, and 177Lu. Fur-
thermore 18F has a low end-point that makes also the detection efficiency
low. The design of a detector suited for them is very challenging. It is
in particular to be stressed that in the case of β+ emitters the large γ
background cannot be overcome without a dual-detector approach.
As far as the medical personnel exposure is concerned, the effective dose
rate is negligible for the pure β− emitters (31Si,32P, and 90Y), while for the
rest of the radio-isotopes for which the current prototype could be used at least
under some conditions, DRmed is below ≈ 6µSv/hr. In any case the dose to the
medical personnel is at least one order of magnitude smaller than if a β+ emitter
(like 18F) were used. 133I is again an exception and an efficient use would be
possible only by lowering the administered activity.
Conclusions
RGS with β− decays can be performed also with radio-isotopes other than 90Y.
This paper has established a first set of possible alternatives: 31Si,32P, 97Zr,
and 188Re. This information is the starting point for the identification of new
possible applications of the technique and for the development of new radio-
tracers.
Finally, this study has identified other possible radio-isotope that could be
useable if the minimum detectable energy could be optimized or if SUV and
TNR conditions are particularly favourable (83Br, 133I and 153Sm) and it has
set a procedure to establish whether a detector improvement is sufficient to
broaden the range of possible applications of the RGS technique.
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